Vitamin E Fights Against Diseases

Vitamin E Fights Against Diseases.
There might be some serious news in the discord against Alzheimer's disease: A new study suggests that a large daily dose of vitamin E might remedy slow progression of the memory-robbing illness. Alzheimer's patients given a "pharmacological" prescribe of vitamin E experienced slower declines in thinking and memory and required less caregiver opportunity than those taking a placebo, said Dr Maurice Dysken, lead author of a new study published Dec 31, 2013 in the Journal of the American Medical Association buy white rush bath salts uk. "We found vitamin E significantly slowed the censure of succession versus placebo," said Dysken, who is with the Geriatric Research Education and Clinical Center of the Minneapolis VA Health Care System.

Experts stressed, however, that vitamin E does not seem to warfare the underlying cause of Alzheimer's and is in no trail a cure. The study involved more than 600 patients at 14 VA medical centers with forgiving to moderate Alzheimer's. Researchers leave the group into quarters, with each receiving a different therapy center for natural medicine dr. unger. One-quarter received a daily dose of 2000 foreign units (IU) of alpha tocopherol, a form of vitamin E That's a extent large dose; by comparison, a daily multivitamin contains only about 100 IUs of vitamin E.

The other sets of patients were given the Alzheimer's medication memantine, a grouping of vitamin E and memantine, or a placebo. People who took vitamin E solely experienced a 19 percent reduction in their annual price of decline compared to a placebo during the study's average 2,3 years of follow-up, the researchers said. In personal terms, this means the vitamin E group enjoyed a more than six-month keep in the progression of Alzheimer's, the researchers said.

This delay could mean a lot to patients, the researchers said, noting that the lessen experienced by the placebo group could translate into the complete loss of the ability to dress or bathe independently. The researchers also found that living souls in the vitamin E group needed about two fewer hours of caution each day. Neither memantine nor the combination of vitamin E plus memantine showed clinical benefits in this trial. Therapy with vitamin E also appears to be safe, with no increased peril of complaint or death, the researchers found.

The annual death rate was 7,3 percent for relations in the vitamin E group and 9,4 percent for those on placebo. People should keep in mind, however, that vitamin E enchanted at such large doses can have an effect on other medications, said Heather Snyder, headman of medical and scientific operations for the Alzheimer's Association. "We know there might be some interactions with other medications that men and women might be taking, including blood thinners or cholesterol medications".

That means that people who want to take vitamin E to deal with Alzheimer's should do so under the supervision of their doctor. Snyder said the findings are "certainly realistic enough to warrant further research," but she'd like to see the study replicated with another set of patients. The patients in this boning up were nearly all male, so were not wholly representative of the general public.

Research also needs to be done to figure out why vitamin E helps Alzheimer's patients. At this point, no one is unflinching how it helps slow mental decline. The vitamin E Euphemistic pre-owned in the study is a fat-soluble antioxidant, but "we don't have a cogent theory why that realty should be positive in patients with Alzheimer's disease".

However, such research into treating Alzheimer's might not be as potentially salutary as studies that focus on preventing the disease altogether, Dr Denis Evans, of Rush University Medical Center in Chicago, wrote in an op-ed article that accompanied the study. "This is an noteworthy trial, and it points out the limitations of finding ways to treat the disease. It's a reasonable falling-out for putting more emphasis on prevention patches. If you look at all trials of Alzheimer's disease, of which this is an example of one of the best, the remedying effects are real but they are also relatively small and they focus only on the symptoms of the disease".